Biochemical diagnosis of pheochromocytoma and neuroblastomas;Diagnostic biochimique du phéochromocytome et du neuroblastome

Annales de Biologie Clinique

Volumn 60, Issue 1, 2002, Pages 15-36

  Candito, M ^a   Billaud, E ^a   Chauffert, M ^a   Cottet Emard, J M ^a   Desmoulin, D ^a   Garnier, J P ^a   Greffe, J ^a   Hirth, C ^a   Jacob, N ^a   Millot, F ^a   Nignan, A ^a   Patricot, M C ^a   Peyrin, L ^a   Plouin, P F ^a  

^a PASTEUR HOSPITAL   (France)

Author keywords

Catecholamines; HVA; Metanephrine; Neuroblastomas; Pheochromocytoma; VMA

Indexed keywords

CATECHOLAMINE; CREATININE; DOPAMINE; HOMOVANILLIC ACID; METADRENALIN; VANILMANDELIC ACID; HYDROXYLAMINE; METHOXYAMINE;

AGE; ANALYTIC METHOD; ANALYTICAL ERROR; BLOOD ANALYSIS; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CREATININE URINE LEVEL; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ELECTROCHEMICAL DETECTION; FRANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; MASS SCREENING; MEDICAL LITERATURE; NEUROBLASTOMA; NORMAL VALUE; PHEOCHROMOCYTOMA; REVIEW; SENSITIVITY AND SPECIFICITY; URINALYSIS; ADOLESCENT; CHILD; INFANT; METABOLISM; PRESCHOOL CHILD; QUALITY CONTROL;

ADOLESCENT; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; HOMOVANILLIC ACID; HUMANS; HYDROXYLAMINES; INFANT; NEUROBLASTOMA; PHEOCHROMOCYTOMA; QUALITY CONTROL; VANILMANDELIC ACID;

EID: 0036364955     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Méthodes recommandées pour le dosage des catécholamines et de leurs métabolites dans l'urine
2. Determination of catecholamines in urine by reverse-phase liquid chromatography with electrochemical detection
3. Analysis for urinary catecholamines by liquid chromatography with amperometric detection: Methodology and clinical interpretation of results
4. Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man
5. Determination of plasma catecholamines and free DHPA in continuously collected human plasma by high performance liquid chromatography with electrochemical detection
6. Stability of catecholamines in whole blood, plasme, and platelets
7. Optimal collection and storage conditions for catecholamine measurements in human plasma and urine
8. Effect of haemolysis on high-performance liquid chromatography measurements of free plasma catecholamines
9. Détermination de la noradrénaline plasmatique par chromatographie liquide haute performance en mode automatique avec détection électrochimique
10. The estimation of catecholamines in human plasma
11. Proposal for the standardization of the calibration method for the assay of plasma catecholamines
12. Plasma catecholamine assays: Calibration with spiked plasma verus aqueas solutions
13. Comparison de onze détecteurs électrochimiques utilisés en chromatographie liquide haute performance
14. Diagnosis efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma
15. Determination of free and conjugated normetanephrine and metanephrine in human plasma by high performance liquid chromatography with electrochemical detection
16. Measurement of plasma methoxyamines for the diagnosis of pheochromocytoma
17. Le dosage des méthoxyamines plasmatiques: Une avancée pratique dans le diagnostic du phéochromocytome
18. Le diagnostic biologique du phéochromocytome: L'impact de l'évolution technologique
19. Determination of plasma methoxyamines
20. Plasma catecholamines levels in children
21. Acetoaminophen adminstration interferes with urinary metanephrine and catecholamine determination
22. Isometric octopamines: Their occurance and functions
23. Élévation de l'excrétion des catécholamines et de leurs catabolites dans le cas d'une tumeur sarcomateuse pulmonaire
24. Epidemiologic study of adrenal gland disorders in Japan
25. A survey on adrenal incidentoloma in Italy. Study GROUP ON Adrenal Tumors of the Italian Society of Endocrinology
26. Biochemical tests for diagnosis of pheochromocytoma: Urinary versus plasma determination
27. Phéochromocytomes: Progrès dans le diagnostic, la prise en charge et la physiopathologie
28. Pheochromocytomas multiple endocrine neoplasma type 2, and von Hipple-Lindau disease
29. Excrétion urinaire atypique des catécholamines et de leurs catabolites dans un cas de phéochromoytome
30. Circulating and urinary catecholamines in pheochromocytoma. Diagnosis and pathophysiological implications
31. Pheochromocytoma: New concepts and future trends
32. Pheochromocytoma
33. Secretory pattern and blood pressure in pheochromocytoma
34. Recent developments in pheochromocytoma diagnosis and imaging
35. Les méthoxymines plasmatiques dans le diagnostic du phéochromocytome
36. The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma
37. Plasma metanephrines in the diagnosis of pheochromocytoma
38. Solid tumors
39. Screening for neuroblastoma in France: Methodological aspects and preliminary observations
40. Clinical progress in neuroblastoma
41. Chromosomal aberrations in human neuroblastomas
42. Chromosome localization in normal human cells and neuroblastomas of a gene related to N-myc
43. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
44. Cytogenetic features of human neuroblastomas and cell lines
45. Gene amplification in cancer: A molecular cytogenetic approach
46. High-affinity NGF binding requirs coexpression of the trk proto-oncogene and the low-affinity NGF receptor
47. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma
48. Cytotoxic action of prostaglandin D2 on mouse neuroblastoma cells
49. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma
50. Neuroblastomes traités à l'Institut Gustave-Roussy de 1975 à 1979. Cent soixante-treize cas
51. Cases of neuroblastoma missed by the mass screening programs
52. Mass screening of neuroblastoma in Sapporo City, Japan
53. 5-Year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations
54. Le neuroblastome de l'enfant: Aspects cliniques et biologiques. Une expérience de dépistage en France
55. Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into gangioneuroma
56. Methylated catecholamine metabolites for diagnosis of neuroblastoma
57. Increased urinary catecholamines in a hypertensive child with renal artery stenosis
58. Neuroblastomes. Aspects cliniques et thé rapeutiques actùels. Apports de la biologie moderne
59. 3,4-Dihydroxyphenylalanine (DOPA) metabolism in screening-detected and non-screening-detected neuroblastoma